Results 131 to 140 of about 1,203,684 (291)

The impacts of the COVID-19 pandemic on China's green bond market. [PDF]

Financ Res Lett, 2021
Yi X, Bai C, Lyu S, Dai L.
europepmc   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Sustainable Financial Transformation: The Role of Green Bond Policy and SDGS Index in ASEAN

Dialektika: Jurnal Ekonomi dan Ilmu Sosial
This study delves into the dynamics of green bond issuance in ASEAN-5 (Indonesia, Malaysia, Singapore, the Philippines, and Thailand) and its key determinants, particularly green bond policies and the SDGs Index. Using secondary data from the IMF, World
Anisha Anisha, Panca Wijaya, Eogenie Lakilaki, Tri Wahyuni, Muhammad Dito Jastian Sidik, Alhafiz Alhafiz   +5 more
doaj   +1 more source

Impacts of COVID-19 outbreak, macroeconomic and financial stress factors on price spillovers among green bond. [PDF]

Int Rev Financ Anal, 2022
Mensi W, Rehman MU, Vo XV.
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Green bond as a new determinant of sustainable green financing, energy efficiency investment, and economic growth: a global perspective. [PDF]

Environ Sci Pollut Res Int, 2023
Ning Y, Cherian J, Sial MS, Álvarez-Otero S, Comite U, Zia-Ud-Din M.   +5 more
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Green Bond Reporting

Columbia Business Law Review
Are green bonds really “green”? A number of legal scholars have addressed various aspects of this critical question. However, none has focused on issuers’ post-issuance assertions about what they spend the bond proceeds on and on the way those assertions are, or are not, verified.
openaire   +2 more sources

Impact of financial inclusion and green bond financing for renewable energy mix: implications for financial development in OECD economies. [PDF]

Environ Sci Pollut Res Int, 2022
Li N, Pei X, Huang Y, Qiao J, Zhang Y, Jamali RH.   +5 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source